BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32075697)

  • 1. Carbapenemase-producing Enterobacteriaceae circulating in the Reunion Island, a French territory in the Southwest Indian Ocean.
    Miltgen G; Cholley P; Martak D; Thouverez M; Seraphin P; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Cimon CB; Ramiandrisoa M; Picot S; Lignereux A; Masson G; Allyn J; Allou N; Mavingui P; Belmonte O; Bertrand X; Hocquet D
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):36. PubMed ID: 32075697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of carbapenemase-producing Enterobacteriaceae in the Indian Ocean Region between January 2010 and December 2015.
    Holman AM; Allyn J; Miltgen G; Lugagne N; Traversier N; Picot S; Lignereux A; Oudin C; Belmonte O; Allou N
    Med Mal Infect; 2017 Sep; 47(5):333-339. PubMed ID: 28602387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
    Miltgen G; Bonnin RA; Avril C; Benoit-Cattin T; Martak D; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Filleul L; Subiros M; de Montera AM; Cholley P; Thouverez M; Dortet L; Bertrand X; Naas T; Hocquet D; Belmonte O
    Int J Antimicrob Agents; 2018 Sep; 52(3):416-420. PubMed ID: 29807164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
    Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
    Lefebvre B; Lévesque S; Bourgault AM; Mulvey MR; Mataseje L; Boyd D; Doualla-Bell F; Tremblay C
    PLoS One; 2015; 10(4):e0125076. PubMed ID: 25910041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.
    Park JW; Lee H; Park SY; Kim TH
    Antimicrob Resist Infect Control; 2019; 8():48. PubMed ID: 30873279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
    Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).
    Österblad M; Kirveskari J; Hakanen AJ; Tissari P; Vaara M; Jalava J
    J Antimicrob Chemother; 2012 Dec; 67(12):2860-4. PubMed ID: 22855858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
    Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
    J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey.
    Logan LK; Hujer AM; Marshall SH; Domitrovic TN; Rudin SD; Zheng X; Qureshi NK; Hayden MK; Scaggs FA; Karadkhele A; Bonomo RA
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3462-9. PubMed ID: 27021322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
    Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
    J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013.
    Ohno Y; Nakamura A; Hashimoto E; Matsutani H; Abe N; Fukuda S; Hisashi K; Komatsu M; Nakamura F
    J Infect Chemother; 2017 Apr; 23(4):224-229. PubMed ID: 28161293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
    Vlek AL; Frentz D; Haenen A; Bootsma HJ; Notermans DW; Frakking FN; de Greeff SC; Leenstra T;
    Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1089-96. PubMed ID: 27126332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.
    Sidjabat HE; Townell N; Nimmo GR; George NM; Robson J; Vohra R; Davis L; Heney C; Paterson DL
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4059-66. PubMed ID: 25918153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012-2018.
    Räisänen K; Lyytikäinen O; Kauranen J; Tarkka E; Forsblom-Helander B; Grönroos JO; Vuento R; Arifulla D; Sarvikivi E; Toura S; Jalava J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1651-1656. PubMed ID: 32307627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.